| | | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2025 ( Subtotal = $10,841,212 ) (Continued on the next page) |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA297076 | Protein-nanoparticle interaction to study multicellular crosstalk within ovarian tumor microenviroment | 000 | 1 | NIH | 1/16/2025 | $326,103 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA287044 | Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub | 000 | 2 | NIH | 12/5/2024 | $738,924 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R13HD117635 | Be Curious, Not Judgmental: The 4th National Symposium on Sexual Behavior of Youth | 000 | 1 | NIH | 1/20/2025 | $10,000 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA255840 | Chemotherapy-induced vascular cognitive impairment: role of endothelial senescence | 000 | 5 | NIH | 12/17/2024 | $298,519 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31AI189149 | Human gut Bacteroidales defense mechanisms against emerging antibacterial toxins | 000 | 1 | NIH | 11/20/2024 | $46,402 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA260449 | Exploiting gold nanoparticle as a probe to identify therapeutic targets | 000 | 4 | NIH | 11/20/2024 | $319,463 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HD109784 | Prevention of Necrotizing Enterocolitis | 000 | 3 | NIH | 1/24/2025 | $368,415 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | OT2OD038371 | Primary Care Research in More Environments in Oklahoma (PRIME-OK) | 000 | 1 | NIH | 1/17/2025 | $1,260,980 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HL161008 | Biomarker-guided optimization of transcutaneous vagal stimulation for atrial fibrillation | 000 | 4 | NIH | 12/19/2024 | $379,891 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA298165 | A Randomized Factorial Trial of Varenicline with Nicotine Lozenges and a Smartphone Medication Adherence Intervention to Promote Smoking Cessation | 000 | 1 | NIH | 12/17/2024 | $625,201 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK131064 | Sulfur Amino Acid Metabolism and Regulation of Hepatic Metabolic Flexibility | 000 | 4 | NIH | 12/13/2024 | $370,911 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 00 | 29 | HRSA | 12/4/2024 | $293,192 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA233193 | A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | 001 | 6 | NIH | 3/7/2025 | $1,163,038 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H7600185 | Ryan White Part C Outpatient EIS Program | 01 | 29 | HRSA | 3/6/2025 | -$293,192 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U01DK135007 | Identifying Metabolic and Psychosocial Antecedents and Characteristics of youth-onset Type 2 diabetes (IMPACT DM) | 000 | 3 | NIH | 2/14/2025 | $569,717 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31AI189149 | Human gut Bacteroidales defense mechanisms against emerging antibacterial toxins | 001 | 1 | NIH | 11/20/2024 | $0 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA053342 | Beta-Adrenergic Modulation of Drug Cue Reactivity: Neural and Behavioral Mechanisms | 000 | 4 | NIH | 3/21/2025 | $525,353 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK134316 | Novel Roles of Cullin-RING E3 Ligases in Liver Pathophysiology | 000 | 3 | NIH | 2/17/2025 | $353,583 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK133207 | ROCK, tight junctions and prematurity in the pathogenesis of necrotizing enterocolitis and neonatal sepsis. | 000 | 3 | NIH | 2/17/2025 | $434,040 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R13HD117635 | Be Curious, Not Judgmental: The 4th National Symposium on Sexual Behavior of Youth | 001 | 1 | NIH | 3/26/2025 | $0 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK139443 | Evaluating PQQ for preventing maternal obesity-induced fetal programming of juvenile NAFLD in Papio anubis | 000 | 2 | NIH | 3/5/2025 | $559,845 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01MD015295 | HealthyCells: A Culturally-Tailored Smoking Cessation Smartphone Intervention for African Americans with Adjunctive Treatment for Sedentary Behavior | 000 | 5 | NIH | 2/18/2025 | $121,243 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DK129656 | Understanding the metabolic pathology of pediatric obesity and NAFLD | 000 | 4 | NIH | 3/5/2025 | $503,196 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01EY028608 | Caveolae-Based Mechanosensors for Conventional Outflow Regulation | 000 | 6 | NIH | 3/13/2025 | $604,777 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H3306689 | EMSC Partnership Grants | 00 | 20 | HRSA | 3/19/2025 | $85,110 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F31AI179208 | Toxin B receptor mediated events in Clostridioides difficile disease | 000 | 2 | NIH | 1/10/2025 | $36,574 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA253391 | Normalizing aberrant metabolism in ovarian cancer by a unique drug delivery system | 000 | 5 | NIH | 1/8/2025 | $330,560 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | K01DA055073 | Identifying and Addressing the Effects of Social Media Use on Young Adults' E-Cigarette Use: A Solutions-Oriented Approach | 000 | 3 | NIH | 1/9/2025 | $198,612 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R03CA289562 | Role of JMJD4 in Breast Cancer | 000 | 2 | NIH | 2/13/2025 | $72,500 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21EY035725 | Targeting Innate Inflammation Pathways to Treat Ocular Infections | 000 | 2 | NIH | 12/20/2024 | $217,500 |
| 2025 | 2025 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R00GM141267 | Identification of novel osmosensing receptors in C. elegans | 000 | 4 | NIH | 1/21/2025 | $224,100 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AA031528 | Examining alcohol-induced blackouts in young adults using alcohol sensors | 000 | 1 | NIH | 12/4/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM083028 | SAMHSA's Suicide Prevention Resource Center grant. | 000 | 5 | SAMHSA | 2/10/2025 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H4B15502 | Poison Control Stabilization and Enhancement Program | 01 | 16 | HRSA | 11/27/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01HD110585 | Preconception Maternal Nutrition, Offspring DNA Methylation, and InfantGrowth in Low Resource Settings | 000 | 2 | NIH | 1/22/2025 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | U19MD020537 | Improving Cancer Outcomes In Native American Communities (ICON) | 000 | 1 | NIH | 12/18/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | F99AG079813 | Reversing age-related epigenetic changes and characterizing microglia heterogeneity in obesity and aging | 000 | 2 | NIH | 11/27/2024 | -$8,843 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01CA276594 | Randomized Controlled Trial of Dyadic Financial Incentive Treatment for Dual Smoker Couples: Evaluation of Efficacy, Mechanisms, and Cost Effectiveness | 001 | 2 | NIH | 2/13/2025 | $266,503 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21CA281135 | Improving Rates of Diagnostic Colonoscopy in Native Americans through a Culturally Sensitive Digital Outreach Intervention | 000 | 1 | NIH | 11/13/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01DA059480 | Elucidating minority stress influences on tobacco use at the intersection of sexual orientation and rurality | 000 | 1 | NIH | 10/17/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | H79SM085083 | Stronger Together: Attachment, Resilience, & Support (STARS): Helping Children and Youth Reach Their Full Potential | 000 | 2 | SAMHSA | 1/23/2025 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG070086 | The Effects of Diet and Exercise Interventions in Peripheral Artery Disease | 002 | 3 | NIH | 12/16/2024 | $214,438 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R33AG072137 | A New Translational Rat Model for Evaluating Anti-Aging Interventions | 000 | 3 | NIH | 11/12/2024 | $28,423 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21AI175595 | Functional and transcriptome analyses of protein kinases in Candida glabrata antifungal drug resistance | 001 | 2 | NIH | 10/28/2024 | $153,599 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21MD019345 | Ecological momentary assessment of daily minority stressors and cannabis and tobacco co-use among sexual minority young adults | 000 | 1 | NIH | 10/15/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R01AG072295 | Cerebromicrovascular rejuvenation by heterochronic blood exchange | 000 | 2 | NIH | 10/15/2024 | $93,522 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R21MH138954 | Social Comparison on Social Media, Depressive Symptoms, and Body Dissatisfaction among Adolescents | 000 | 1 | NIH | 10/25/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | UG1CA233193 | A Lead Academic Participating Site in Oklahoma for the Design and Conduct of NCTN Clinical Trials | 000 | 6 | NIH | 10/23/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF OKLAHOMA | 865 RESEARCH PKWY | OKLAHOMA CITY | OK | 73104-3609 | OKLAHOMA | USA | R34DA060534 | Developing An Empowerment Theory-Based Smoking Cessation Intervention for Sexual and/or Gender Minority People with Community Partners | 000 | 1 | NIH | 10/24/2024 | $0 |
|